Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This phase I/II clinical trial is an open-label clinical trial design to verify safety and dosing for TAVT-18 (sirolimus) powder for oral solution in TSC infants (N=5).
Epistemonikos ID: 1d6d24541c01345e0e9465718470f4a27b5a2dc1
First added on: May 07, 2024